• US: +1-408-610-2300
  • Toll Free: +1-866-831-4085
  • Login / Register
Tissue Ablation Products Market To Grow Owing To Rising Cases Of Cardiovascular Disorders
Published On: August 2, 2019

The global tissue ablation products market is estimated to witness a healthy CAGR during the forecast period 2013 to 2028, according to a report available on Million Insights. The issue ablation products are defined as advanced medical instruments that are used to destroy unwanted or diseased tissues without removing them. Conventional or invasive surgical methods involved long cuts, stitches, and blood loss. Patient’s use to take too long to recover due to weakness. Tissue ablation is a non-invasive method that supports surgeons to reduce recovery time for patients.

Rising cases of cardiovascular disorders such as paroxysmal, persistent and permanent atrial fibrillation, and arrhythmia are anticipated to propel market growth. Increase in prevalence of chronic diseases such as cancer is driving demand for tissue ablation products. In case of cancer, surgeons have to remove the infected tissue from patient’s tissue through surgery. Ablation allows surgeons to destroy infected tissues without removing them. In addition, growing awareness about health benefits of non-invasive surgical procedures is expected to impel market growth. Moreover, technological advancements in medical devices to improve precision, power, and control required for selective dissection of tissues will drive the market over the forecast period.

Access full report on global Tissue Ablation Products Market: https://www.millioninsights.com/industry-reports/tissue-ablation-products-market

To cater to rising demand for non-invasive surgical equipment, manufacturing companies are investing in R&D to develop advanced medical devices. For instance, in February 2019, Medtronic received food and drug administration (FDA) clearance for its Accurian radio frequency (RF) ablation system for nerve tissues. The system sends radiofrequency signals to targeted nerves and reduces pain using heat. After ablation, tissue is not able to generate pain signals. Hence, target has to accurate to get maximum results. To prevent permanent damage to surrounding tissues, the system relies on quad core computer for controlling heat.

The tissue ablation products market can be segregated on the basis of product type, application, and region. Based on product type, the market can be categorized into radiofrequency system, microwave system, radiation therapy systems, photonic or laser based systems, cryotherapy systems, and others. In terms of application, the market can be classified into aesthetic surgery, general surgery, oncology, gynecology, and others.

Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East and Africa. North America is anticipated to account for significant market share attributed to increasing number of geriatric population in the region. Elderly people are liable to chronic disorders due to lack of immunity in their body. This factor is likely to impel demand for tissue ablation in the region.  

Some of the leading companies operating in the tissue ablation products market are Abbott Laboratories, Medtronic, Cynosure, Hologic, and Spectranetics.

Ryan Manuel
Research Support Specialist, USA
Million Insights
Email: [email protected]